NDA 18713, held by Bayer Hlthcare. Clotrimazole.
As of Nov 13, 2026, NDA 18713 (Mycelex), held by Bayer Hlthcare, was first approved by FDA on Jun 17, 1983, with 15 approved supplements and 0 published complete response letters.
| Sep 29, 1992 | Supplement 7Efficacy (new indication or use) | Approved | None posted |
| Jun 17, 1983 | Original applicationNew dosage form · Standard review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Mycelex10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · troche/lozenge;oral | Clotrimazole | DiscontinuedReference drug |
| Dec 15, 2002 | Supplement 19Labeling · Standard review | Approved | |
| Mar 26, 2001 | Supplement 17Manufacturing · Standard review | Approved | |
| Jan 23, 2001 | Supplement 16Manufacturing · Standard review | Approved | None posted |
| Oct 7, 1999 | Supplement 14Manufacturing · Standard review | Approved | |
| Jun 30, 1999 | Supplement 13Manufacturing · Standard review | Approved | None posted |
| Sep 29, 1992 | Supplement 7Efficacy (new indication or use) | Approved | None posted |
| Dec 30, 1991 | Supplement 11Labeling | Approved | None posted |
| Jan 18, 1990 | Supplement 10Manufacturing · Standard review | Approved | None posted |
| Sep 15, 1989 | Supplement 9Manufacturing · Standard review | Approved | None posted |
| Dec 7, 1988 | Supplement 8Manufacturing · Standard review | Approved | None posted |
| Jan 27, 1988 | Supplement 5Manufacturing · Standard review | Approved | None posted |
| Jan 15, 1988 | Supplement 6Manufacturing · Standard review | Approved | None posted |
| Jun 3, 1987 | Supplement 4Manufacturing · Standard review | Approved | |
| Sep 11, 1985 | Supplement 2Labeling | Approved | None posted |
| Nov 13, 1984 | Supplement 1Manufacturing · Standard review | Approved | None posted |
| Jun 17, 1983 | Original applicationNew dosage form · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters